Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy
- PMID:17010805
- DOI: 10.1016/j.jacc.2006.06.045
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy
Abstract
Objectives: The purpose of our study was to characterize the penetrance of PKP2 mutations among family members of people with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and to examine clinical features and predictors of disease among PKP2 mutation carriers.
Background: Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterized by fatty-fibrous myocardial replacement of the right ventricle, ventricular arrhythmias, and right ventricular dysfunction. Mutations in PKP2, the gene encoding plakophilin-2, are found in 11% to 43% of ARVD/C probands.
Methods: The study population was composed of 64 individuals in 9 families with an ARVD/C proband previously shown to carry a pathogenic PKP2 mutation. The diagnosis of ARVD/C was established based on task force criteria (TFC) set by the European Society of Cardiology.
Results: In addition to the probands, PKP2 mutations were present in 52% of relatives screened. Forty-nine percent of PKP2 mutation carriers met TFC. Among mutation carriers who did not meet full TFC, 50% met at least some TFC criteria besides family history. Pedigrees showed wide intra-familial variability, ranging from severe disease with early death to individuals who were completely asymptomatic late in life. Male PKP2 mutation carriers were more likely to have structural and conduction abnormalities as determined by imaging studies, signal-averaged electrocardiography, and 24-h ambulatory electrocardiography (p < 0.05).
Conclusions: PKP2 mutations in a group of North American families with ARVD/C have both reduced penetrance and variable expressivity. Gender may have an influence on penetrance of PKP2 mutations, with male mutation carriers more likely to develop specific phenotypic manifestations of this disease.
Similar articles
- Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.Dalal D, Molin LH, Piccini J, Tichnell C, James C, Bomma C, Prakasa K, Towbin JA, Marcus FI, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP.Dalal D, et al.Circulation. 2006 Apr 4;113(13):1641-9. doi: 10.1161/CIRCULATIONAHA.105.568642. Epub 2006 Mar 20.Circulation. 2006.PMID:16549640
- Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.Qiu X, Liu W, Hu D, Zhu T, Li C, Li L, Guo C, Liu X, Wang L, Zheng H, Wang C, Diao Q, Shi D, Zhan P, Deng Y, Liu K, Wang Y, Liu B, Liu H, Zhang L.Qiu X, et al.Am J Cardiol. 2009 May 15;103(10):1439-44. doi: 10.1016/j.amjcard.2009.01.356. Epub 2009 Apr 1.Am J Cardiol. 2009.PMID:19427443
- Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.Bhuiyan ZA, Jongbloed JD, van der Smagt J, Lombardi PM, Wiesfeld AC, Nelen M, Schouten M, Jongbloed R, Cox MG, van Wolferen M, Rodriguez LM, van Gelder IC, Bikker H, Suurmeijer AJ, van den Berg MP, Mannens MM, Hauer RN, Wilde AA, van Tintelen JP.Bhuiyan ZA, et al.Circ Cardiovasc Genet. 2009 Oct;2(5):418-27. doi: 10.1161/CIRCGENETICS.108.839829. Epub 2009 Aug 1.Circ Cardiovasc Genet. 2009.PMID:20031616
- The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy.Ahmad F.Ahmad F.Clin Invest Med. 2003 Aug;26(4):167-78.Clin Invest Med. 2003.PMID:12934820Review.
- Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?van Tintelen JP, Hofstra RM, Wiesfeld AC, van den Berg MP, Hauer RN, Jongbloed JD.van Tintelen JP, et al.Curr Opin Cardiol. 2007 May;22(3):185-92. doi: 10.1097/HCO.0b013e3280d942c4.Curr Opin Cardiol. 2007.PMID:17413274Review.
Cited by
- Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report.Güdücü N, Kutay SS, Ozenç E, Ciftçi C, Yiğiter AB, Işçi H.Güdücü N, et al.J Med Case Rep. 2011 Jul 10;5:300. doi: 10.1186/1752-1947-5-300.J Med Case Rep. 2011.PMID:21740597Free PMC article.
- Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease.Qian L, Mohapatra B, Akasaka T, Liu J, Ocorr K, Towbin JA, Bodmer R.Qian L, et al.Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19833-8. doi: 10.1073/pnas.0808705105. Epub 2008 Dec 11.Proc Natl Acad Sci U S A. 2008.PMID:19074289Free PMC article.
- Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA; Multidisciplinary Study of Right Ventricular Dysplasia Investigators.Xu T, et al.J Am Coll Cardiol. 2010 Feb 9;55(6):587-97. doi: 10.1016/j.jacc.2009.11.020.J Am Coll Cardiol. 2010.PMID:20152563Free PMC article.
- The Novel Variant NP_00454563.2 (p.Glu259Glyfs*77) in GenePKP2 Associated with Arrhythmogenic Cardiomyopathy in 8 Families from Malaga, Spain.Robles-Mezcua A, Ruíz-Salas A, Medina-Palomo C, Robles-Mezcua M, Díaz-Expósito A, Ortega-Jiménez MV, Gimeno-Blanes JR, Jiménez-Navarro MF, García-Pinilla JM.Robles-Mezcua A, et al.Genes (Basel). 2023 Jul 19;14(7):1468. doi: 10.3390/genes14071468.Genes (Basel). 2023.PMID:37510372Free PMC article.
- The challenge of diagnosing arrhythmogenic right ventricular cardiomyopathy in the young.Sanatani S, Duncan W, Chan S.Sanatani S, et al.Pediatr Cardiol. 2008 Jul;29(4):800-3. doi: 10.1007/s00246-008-9238-8. Epub 2008 Apr 22.Pediatr Cardiol. 2008.PMID:18427879
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous